Concepedia

Cathryn Rankin

CR

Statistics

Publications

37

Citations

4.8K

H-Index

26

Active since

1988

Affiliations

SWOG Cancer Research Network(Current)

Cancer Research And Biostatistics

Cleveland Clinic

Fred Hutch Cancer Center

University of Southern California

Cathryn Rankin is an author at SWOG Cancer Research Network specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1988–2017

37

Publications

37

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Charles D. Blanke, Cathryn Rankin, George D. Demetri et al. · Journal of Clinical Oncology · 2008 · 1.1K citations

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

Michael C. Heinrich, Kouros Owzar, Christopher L. Corless et al. · Journal of Clinical Oncology · 2008 · 649 citations · Full text

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

Piotr Rutkowski, M. van Glabbeke, Cathryn Rankin et al. · Journal of Clinical Oncology · 2010 · 398 citations · Full text

Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors (GIST): A meta-analyis based on 1,640 patients (pts)

M. M. Van Glabbeke, Kouros Owzar, Cathryn Rankin et al. · Journal of Clinical Oncology · 2007 · 383 citations

, , +13

Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study

Linda L. Garland, Cathryn Rankin, David R. Gandara et al. · Journal of Clinical Oncology · 2007 · 218 citations · Full text

1–5 of 37